dr. goy on acalabrutinib versus ibrutinib in mcl
Published 6 years ago • 881 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
0:46
dr. goy compares acalabrutinib with ibrutinib in mcl
-
1:46
dr. o'connor on acalabrutinib versus ibrutinib in mcl
-
1:03
dr. woyach on the safety of acalabrutinib versus ibrutinib in cll
-
1:06
dr. goy on promising data with acalabrutinib in mcl
-
1:24
dr. goy on preliminary data with ibrutinib/venetoclax in relapsed/refractory mcl
-
1:06
dr. goy on efficacy with ibrutinib in mcl
-
1:33
dr. jacobs on the efficacy of ibrutinib and acalabrutinib in patients with mcl
-
1:10
dr. wang on the toxicity of ibrutinib, acalabrutinib, and zanubrutinib in mcl
-
1:25
dr. goy discusses single-agent ibrutinib in mcl
-
0:58
dr. leslie on the benefits with zanubrutinib in mcl
-
1:09
dr. goy discusses ibrutinib with venetoclax in mcl
-
4:55
first results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated ch...
-
1:02
dr. goy on the progression of mcl treatment
-
0:53
andre goy, md, discusses the best strategy for using ibrutinib in mcl
-
1:50
dr. mato on ibrutinib versus acalabrutinib in cll
-
1:28
dr. goy on the evolution of treatment selection in mcl
-
1:32
selecting btk inhibitors for patients with mcl
-
1:27
dr. rule on the combination of venetoclax and ibrutinib in mcl
-
0:51
dr. goy on bendamustine plus cytarabine as mcl treatment